Breaking
Friday, June 19, 2026
Whitepaper US Score 85/100

Scientific Standards for 23andMe's Health and Trait Reports

This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.

Publisher
23andMe
Published
Length
8 pages
File
240 KB PDF
Scientific Standards for 23andMe's Health and Trait Reports — cover

Quick answer

Scientific Standards for 23andMe's Health and Trait Reports is a 8-page whitepaper from 23andMe covering US pharma intelligence. This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.

Research library Data sources More from 23andMe

High impact 23andMe 4 min read

Why this matters

This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.

Executive summary

  • This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.

Market Impact

Regulatory high
Commercial high
Competitive medium
Investment high

Who should read this

  • Regulatory affairs teams

Ask about this report

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Download the full 8-page PDF

Free · 240 KB · Instant access after email

🔒 We never share your email. Single-click download.
# Executive Summary This white paper details the scientific standards employed by 23andMe for their Health and Trait reports, focusing on: - **Clinical and Analytical Validity**: Reports must meet strict standards for validity and reliability. - **Evidence Sources**: Genetic associations are based on peer-reviewed studies and clinical guidelines. - **Report Types**: Includes Carrier Status, Genetic Health Risk, and Pharmacogenetics reports, each with specific criteria for variant inclusion. - **Regulatory Compliance**: All reports are regulated by the U.S. FDA to ensure clinical and analytical validity. - **Evaluation Criteria**: Studies are assessed for population size, methodology, and statistical significance to ensure robust findings.

Frequently asked questions

What whitepapers does NovaPharmaNews publish?

Our research library curates FDA, EMA, and industry publisher PDFs — regulatory guidance, clinical analyses, manufacturing reports, and market intelligence. Each report includes an AI-summarized landing page with key takeaways and a gated PDF download.

How do I download a whitepaper?

Open any report page, scroll to the download form, and enter your work email. You receive instant PDF access and can opt in to weekly pharma intelligence updates. Downloads are free for healthcare professionals.

How do whitepapers connect to news and pipeline data?

Report pages link to related intelligence — company profiles, drug INN pages, clinical trials, pipeline programs, and topic hubs. Use the intelligence spokes on each page to explore the entity graph behind the research.

Ready to read the full report?

Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.

Download PDF

Related topic hubs

Editorial coverage and intelligence directories for this report's beat.

Explore the intelligence platform